Poster an Exhibition Hall Reception For more information about the congress, please visit crohnscolitiscongress.org. Palisade Bio is a clinical-stage biopharmaceutical company focused on developing ...
The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...
Researchers have uncovered differences in how patients with South Asian and white ethnicity present with inflammatory bowel ...
Turmeric's active compound, curcumin, is a potent anti-inflammatory and antioxidant that can help with conditions like ...
In a major breakthrough, researchers in the UK have discovered a potential root cause of inflammatory bowel disease (IBD), a condition that affects millions globally. The discovery could revolutionize ...
Wearable devices can identify, differentiate, and predict flare-ups, or the worsening of symptoms and inflammation, in inflammatory bowel disease (IBD), Mount Sinai researchers have shown in a ...
Children who were diagnosed with inflammatory bowel disease (IBD) showed a decline in height, weight, and body mass index ...
The U.S. Food and Drug Administration has approved Eli Lilly's Omvoh (mirikizumab-mrkz) for the treatment of moderately to ...
More than half (53%) of patients reached remission after one year of Omvoh treatment and 46% experienced healing of the ...
LOS ANGELES, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company ...